A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry age-related macular degeneration, according to a report by a working group of...
Saghar Bagheri, MD, Clinical Research Fellow at Mass. Eye and Ear under the mentorship of Dr. Demetrios Vavvas, has been invited to participate in the Members-in-Training Outstanding Poster Award...
Attendance for the 3rd Biennial International Symposium on Ocular Regeneration and the 5th Biennial International Symposium on AMD continues to climb each year, reflecting the high caliber of these...
As part of the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program, Neena Haider, PhD, and Hajirah Saeed, MD, met with Congress members and their legislatorson September...
Findings may lead to earlier diagnoses and better prognostic information for patients — and, potentially, new pharmaceutical targets for AMD treatment.
At the fourth Biennial International Symposium on AMD, held October 21-22, 2016 in Boston, more than 200 clinicians, researchers, trainees, and industry representatives discussed current AMD topics...
On September 21-22, 2012, Harvard Ophthalmology hosted its 2nd Biennial International Symposium on age-related macular degeneration (AMD), which spurred lively discussion and debate among more than...
Drawing nearly 250 clinicians, researchers, trainees, and industry representatives from around the world, the Third International Biennial Symposium on AMD, which was held October 24–25, 2014 and co...
A diverse and distinguished group of clinicians and researchers from around the world enjoyed a stimulating two days of active discussion at the first international AMD symposium hosted by the Harvard...
A phase I/II clinical trial at Massachusetts Eye and Ear found that some patients taking high doses of atorvastatin (cholesterol-lowering medication) had complete resolution of lipid deposits in the...